Description
Lamivir HBV is a potent nucleoside analog reverse transcriptase inhibitor (nRTI). It is marketed by GlaxoSmithKline with the brand names Lamivir HBV has been used for treatment of chronic hepatitis B at a lower dose than for treatment of HIV.
Reviews
There are no reviews yet.